Parvovirus B19 infection as trigger of graft vs. host disease

Eur J Haematol. 2008 Nov;81(5):404. doi: 10.1111/j.1600-0609.2008.01136.x. Epub 2008 Aug 8.

Authors

Gerhard Behre¹, Maximilian Christopeit

Affiliation

¹ Department of Internal Medicine IV, Oncology and Hematology, University Hospital Halle (Saale), Halle (Saale), Germany.

PMID: 18691322
DOI: 10.1111/j.1600-0609.2008.01136.x

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Disease
Adult
Antigens, Viral / immunology
Colitis / drug therapy
Colitis / etiology*
Colitis / immunology
Cross Reactions / immunology
Erythema Infectiosum / complications*
Erythema Infectiosum / drug therapy
Erythema Infectiosum / immunology
Exanthema / drug therapy
Exanthema / etiology*
Exanthema / immunology
Graft vs Host Disease / drug therapy
Graft vs Host Disease / etiology*
Graft vs Host Disease / immunology
Humans
Lymphoma, Mantle-Cell / complications*
Lymphoma, Mantle-Cell / immunology
Lymphoma, Mantle-Cell / therapy
Male
Parvovirus B19, Human* / immunology
Peripheral Blood Stem Cell Transplantation
T-Lymphocytes / immunology
Transplantation Conditioning
Transplantation, Autologous

Substances

Antigens, Viral